Penumbra, Inc Retained Earnings
Penumbra, Inc (PEN) had Retained Earnings of $305.09 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-30
- 2026-06-30: Retained Earnings (Accumulated Deficit) $305.09M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $270.27M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $237.69M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $190.35M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | $305.09M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $270.27M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $237.69M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $190.35M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $144.50M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $99.23M 10-Q · filed 2025-04-23 | |
| 2024-12-31 | $60.00M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $26.01M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $85.66M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $145.86M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $134.86M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $80.64M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $71.43M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $52.47M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $43.90M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $40.03M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $42.30M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $45.98M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $45.91M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $70.54M 10-Q · filed 2021-11-03 | $61.69M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $52.46M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $40.62M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $36.97M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $45.79M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $57.75M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $57.52M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $47.83M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $36.35M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $19.76M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $9.06M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $2.40M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $21.33M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $7.95M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $2.00M 10-K · filed 2019-02-26 | |
| 2017-09-30 | -$7.09M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$7.33M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$5.77M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$2.66M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$264.00K 10-K · filed 2017-02-28 | -$17.62M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$12.17M 10-K · filed 2017-02-28 | -$16.51M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$15.18M 10-K · filed 2017-02-28 | -$16.70M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$17.48M 10-K · filed 2017-02-28 | |
| 2015-09-30 | -$19.11M 10-Q · filed 2015-11-12 | |
| 2014-12-31 | -$19.84M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |